Stablecoins are here to stay says BlackRock
NEW YORK - Waters Corporation (NYSE:WAT) reported better-than-expected first quarter 2025 results and raised its full-year guidance on Tuesday.
The company’s shares were up 0.59% in premarket trading following the release.
The analytical instrument maker posted adjusted earnings per share of $2.25, beating analyst estimates of $2.22. Revenue came in at $662 million, surpassing expectations of $655.33 million and growing 4% YoY, or 7% in constant currency.
Waters saw strong momentum in its pharmaceutical and industrial end markets, with instrument sales growing 11% in constant currency. Overall sales were driven by 8% growth in the pharmaceutical segment and 6% growth in industrial markets.
"Our first-quarter results exceeded expectations, driven by double-digit instrument growth, strength in pharma, and the continued traction of our innovative product portfolio," said CEO Dr. Udit Batra.
Based on the solid Q1 performance, Waters raised its full-year 2025 outlook. The company now expects constant currency sales growth of 5-7%, up from its previous guidance. Waters also increased its full-year adjusted EPS forecast to $12.75-$13.05, above the consensus estimate of $12.87.
For Q2, Waters projects constant currency sales growth of 5-7% and adjusted EPS of $2.88-$2.98.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.